Related Experiment Video
Updated: Mar 3, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Sleep disturbance in mild cognitive impairment: a systematic review of objective measures
Mingyue Hu1, Ping Zhang1, Chen Li1
1College of Nursing, Jilin University, 965 Xinjiang Road, Changchun, 130021, China.
Abstract:
Sleep disturbance frequently occurs in patients with mild cognitive impairment (MCI) and appears to be involved in the cellular and molecular mechanisms of cognitive decline. The aim of this systematic review is to clarify whether patients with MCI demonstrate alterations in certain sleep parameters: total sleep time (TST), sleep efficiency (SE), sleep latency (SL), rapid eye movement latency (REML), percent of rapid eye movement (REM%), arousal index (AI), wake after sleep onset (WASO), slow-wave sleep (SWS), periodic leg movement in sleep (PLMS), and cyclic alternating pattern (CAP) through polysomnography (PSG) and actigraphy. Databases including PubMed, Web of Science, Embase, ScienceDirect, Cochrane, CBM, CNKI, Wanfang Data, and VIP were searched up to January 2016 to collect literature on the correlation between sleep disturbance and MCI as assessed by objective measures. Meta-analysis was conducted using the Review Manager 5.3 software. A total of ten case-control studies involving 225 MCI patients and 235 healthy elders (HE) were deemed eligible and included in our meta-analysis. Every type of sleep disturbance was present in our studies with significant differences in the MCI subtypes. Compared with HE, overall MCI patients as a group expressed more SL and less SE; MCI patients showed less TST and SE and more SL and CAP; patients with amnestic mild cognitive impairment (aMCI) had less AI; patients with non-amnestic mild cognitive impairment (naMCI) had more TST and less AI. Patients with naMCI expressed more AI than those with aMCI. The results indicate that MCI patients might experience more serious sleep disturbance and that different MCI subtypes have different patterns of sleep disturbance.
Insights
Patients with mild cognitive impairment (MCI) experience significant sleep disturbances, including reduced sleep efficiency and increased sleep latency. Different subtypes of MCI show distinct sleep pattern alterations, suggesting sleep disruption is integral to cognitive decline.
Area of Science:
- Neuroscience
- Sleep Medicine
- Gerontology
Background:
- Sleep disturbance is common in mild cognitive impairment (MCI) and may contribute to cognitive decline.
- Objective measures are needed to understand sleep alterations in MCI.
Purpose of the Study:
- To systematically review and meta-analyze objective sleep parameters in MCI patients compared to healthy elders (HE).
- To identify specific sleep alterations associated with different MCI subtypes.
Main Methods:
- Systematic literature search of multiple databases up to January 2016.
- Meta-analysis of ten case-control studies (225 MCI patients, 235 HE) using polysomnography and actigraphy.
Main Results:
- MCI patients exhibited increased sleep latency (SL) and reduced sleep efficiency (SE) compared to HE.
- MCI patients showed reduced total sleep time (TST) and SE, and increased SL and cyclic alternating pattern (CAP).
- Amnestic MCI (aMCI) patients had less arousal index (AI), while non-amnestic MCI (naMCI) patients had more TST and less AI. naMCI patients had higher AI than aMCI patients.
Conclusions:
- MCI patients generally experience more severe sleep disturbances.
- Distinct sleep disturbance patterns are observed in different subtypes of MCI, highlighting the complexity of sleep's role in cognitive impairment.
Related Concept Videos
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

